A Luvaminos LLC publication
Peptide analogs · first-party feedback
See the audited Luvaminos rating distribution and written customer feedback for this mitochondrial-derived research peptide.
Snapshot audited July 11, 2026
2 written records
14 additional star-only rating records are included in the summary without an empty card.
No written review cards match these filters. The rating remains included in the summary above.
“It linked to the correct COA for that lot, confirming the stated purity. The vial labeling was clear and matched the documentation. Packaging prevented any transit damage. The material appears well-suited for our research protocols.”
“Secure packaging. Prompt shipping. Reliable.”
Product review methodology
The 16-record total is the approved first-party rating count returned for MOTS-c. The average and each distribution bar are calculated from those same records.
Written cards appear only when the source record contains a title or comment. Customer feedback is reproduced as supplied after HTML escaping; locations, generated dates, order claims, and external-platform labels are omitted.
Read the complete methodology →MOTS-c review questions
16 approved first-party rating records are included, with an average of 4.81 out of 5.
2 records contain a written title or comment. The other 14 records are star-only ratings and remain included in the summary.
Luvaminos provides a batch-documentation library for its research catalog. Match the available lot details before evaluating the record.
Use the direct catalog link on this page; it leads to the official MOTS-c product route on luvaminos.com.
MOTS-c is sold strictly for laboratory and in-vitro research. It is not for human or veterinary consumption.
